Enhancing the therapeutic efficacy of programmed death ligand 1 antibody for metastasized liver cancer by overcoming hepatic immunotolerance in mice
Bing Xin, Meixiang Yang, Panyisha Wu, Li Du, Xingyu Deng, Enfu Hui, Gen‐Sheng Feng – 2 December 2021